Viatris Inc
VTRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001792044
No open-market purchases or sales by Viatris Inc insiders were filed in the last 90 days; 1,032 institutions reported holding it in 13F filings for Q2 2026, worth $16.6B in total; Greenlight Capital is the only superinvestor holding it.
Q2 2023 vs. Q1 2023
How the institutions holding Viatris Inc changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 993 | 5 | 989 | +1 |
| Shares | 915.4M | 102.5K | 933.8M | +18.5M (+2.0%) |
| Value | $8.79B | $986.9K | $9.32B | +$524.3M (+6.0%) |
5 institutions that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (92)
Institutions that held Viatris Inc at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (91)
Institutions that held Viatris Inc at the end of Q1 2023 and filed for Q2 2023 without it.
Not filed for Q2 2023 yet (5)
Institutions that held Viatris Inc at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| SS&H Financial Advisors, Inc. | 85,809 | $825.5K |
| Euclidean Technologies Management, LLC | 15,666 | $150.7K |
| Householder Group Estate & Retirement Specialist, LLC | 888 | $9.00K |
| Ahrens Investment Partners LLC | 165 | $1.59K |
| Clear Perspectives Financial Planning, LLC | 11 | $106 |